|
|
|
Enzon Pharmaceuticals inc (ENZN) |
|
ENZN's Market share relative to its competitors, as of Q1 2025
As of Q1 2025 (Revenue in Millions of $)
Date modified: 2025-06-23T23:21:12+00:00
|
Select the Relationship:
|
|
Select the Category:
|
|
| COMPANY NAME |
REVENUES
12 Months Ending
Q1 2025 |
MARKET SHARE
12 Months
Q1 2025 |
MARKET SHARE
MRQ
Q1 2025 |
MARKET SHARE
A Quarter Before
Q4 2024 |
| Enzon Pharmaceuticals inc |
1.72 |
0.00% |
0.00 % |
0.00 % |
| Amgen Inc |
33,424.00 |
31.85% |
35.16% |
31.15% |
| Gilead Sciences Inc |
28,735.00 |
27.38% |
25.80% |
27.73% |
| Regeneron Pharmaceuticals Inc |
14,085.70 |
13.42% |
11.72% |
13.88% |
| Vertex Pharmaceuticals Inc |
11,099.70 |
10.58% |
10.72% |
10.67% |
| Biogen Inc |
9,816.40 |
9.35% |
9.41% |
8.99% |
| Seagen Inc |
2,300.35 |
2.19% |
2.51% |
2.21% |
| Exelixis Inc |
2,298.92 |
2.19% |
2.15% |
2.08% |
| Alkermes Plc |
1,513.77 |
1.44% |
1.19% |
1.58% |
| Halozyme Therapeutics Inc |
1,084.31 |
1.03% |
1.02% |
1.09% |
| Iovance Biotherapeutics inc |
212.68 |
0.20% |
0.19% |
0.27% |
| Coherus Biosciences inc |
197.50 |
0.19% |
0.03% |
0.20% |
| Arcellx Inc |
76.81 |
0.07% |
0.03% |
0.06% |
| Innate Pharma Sa |
69.04 |
0.07% |
0.07% |
0.00% |
| Revolution Medicines Inc |
29.51 |
0.03% |
0.00% |
0.00% |
| Mesoblast Ltd |
5.90 |
0.01% |
0.01% |
0.00% |
| Fusion Pharmaceuticals Inc |
0.90 |
0.00% |
0.00% |
0.00% |
| Opthea Limited |
0.12 |
0.00% |
0.00% |
0.00% |
| Aceragen Inc |
0.00 |
0.00% |
0.01% |
0.02% |
| Cardiol Therapeutics inc |
0.00 |
0.00% |
0.00% |
0.00% |
| Ladrx Corporation |
0.00 |
0.00% |
0.00% |
0.00% |
| Zura Bio Limited |
0.00 |
0.00% |
0.00% |
0.00% |
| Cullinan Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| Alvotech |
0.00 |
0.00% |
0.00% |
0.00% |
| SUBTOTAL |
104,952.33 |
100% |
25,845.15 |
100% |
ENZN's Market share relative to its competitors, as of Q1 2025 within the Biotechnology & Pharmaceuticals Industry
As of Q1 2025
ENZN's Market share relative to its competitors, as of Q1 2025 within the Healthcare Sector
As of Q1 2025
Note: Market share is calculated based on total revenue. To get a more accurate picture of Enzon Pharmaceuticals inc's market divisions, geographic dispersion, segments, products, and services, visit Enzon Pharmaceuticals inc's Business Segment. The list includes publicly traded companies only. More information about the sources of this report can be found here. |
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
